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Development of a fertilized human egg into an average sized adult requires about 29 trillion
cell divisions, thereby producing enough DNA to stretch to the Sun and back 200 times
(DePamphilis and Bell, 2011)! Even more amazing is the fact that throughout these mitotic
cell cycles, the human genome is duplicated once and only once each time a cell divides.
If a cell accidentally begins to re-replicate its nuclear DNA prior to cell division, check-
point pathways trigger apoptosis. And yet, some cells are developmentally programmed
to respond to environmental cues by switching from mitotic cell cycles to endocycles, a
process in which multiple S phases occur in the absence of either mitosis or cytokinesis.
Endocycles allow production of viable, differentiated, polyploid cells that no longer prolifer-
ate. What is surprising is that among the 516 (Manning et al., 2002) to 557 (BioMart web
site) protein kinases encoded by the human genome, only eight regulate nuclear DNA
replication directly. These are Cdk1, Cdk2, Cdk4, Cdk6, Cdk7, Cdc7, Checkpoint kinase-1
(Chk1), and Checkpoint kinase-2. Even more remarkable is the fact that only four of these
enzymes (Cdk1, Cdk7, Cdc7, and Chk1) are essential for mammalian development. Here
we describe how these protein kinases determine when DNA replication occurs during
mitotic cell cycles, how mammalian cells switch from mitotic cell cycles to endocycles,
and how cancer cells can be selectively targeted for destruction by inducing them to begin
a second S phase before mitosis is complete.
Keywords: cyclin-dependent kinases, cyclins, checkpoint kinases, mitotic cell cycle, endoreplication, DNA
re-replication, Cdc7, Dbf4
INTRODUCTION
The mitotic cell cycle restricts duplication of mammalian nuclear
DNA to once and only once each time the cell divides. Re-
replication of regions of nuclear DNA that have already been
replicated prior to completion of S phase (termed “DNA re-
replication”) is an aberrant form of the mitotic cell cycle that
ends in cell death. However, some cells are developmentally pro-
grammed to exit their mitotic cell cycle in order to undergo
multiple rounds of nuclear genome duplication without an inter-
vening mitosis (termed “endoreplication”). Here we describe the
characteristics of each of these replication patterns and the roles
played by the eight protein kinases that act directly to link DNA
replication to cell division and to restrict duplication of the nuclear
genome to once and only once per cell division.
THE MITOTIC CELL CYCLE
The mitotic cell cycle is a sequence of events in which the nuclear
DNA of eukaryotic cells is duplicated once and only once each time
a cell divides in order to produce two diploid cells, both of which
contain two complete copies of each chromosome (2C DNA con-
tent). In mitotic cell cycles, nuclear DNA replication is linked to cell
division, and its copy number is strictly regulated, whereas mito-
chondrial DNA replication is not linked to cell division and its copy
number varies widely among cell types (DePamphilis and Bell,
2011). Nuclear DNA replication is controlled directly by only eight
protein kinases. Most cells in adult mammals exist in a quiescent
state termed G0, from which they can reenter their mitotic cell
cycle through the action of two cyclin-dependent protein kinases
(CDK) termed Cdk4 and Cdk6 (Figure 1A; DePamphilis and Bell,
2011). Two other protein kinases,Cdc7 and Cdk2, then drive mam-
malian cells from a period of cell growth (G1 phase) into a period
of nuclear DNA replication (S phase). Upon completion of DNA
replication (G2 phase), a fifth protein kinase (Cdk1) drives the cell
into mitosis while simultaneously inhibiting initiation of the next
S phase by phosphorylating at least one of the proteins required
to initiate DNA replication. However, neither Cdk1 nor Cdk2 are
active unless phosphorylated by Cdk7 at one site and dephos-
phorylated by a Cdc25 protein phosphatase at a different site.
Cdc25 activity is suppressed when it is phosphorylated by Check-
point kinase-1 (Chk1), a protein kinase that is activated by either
stalled replication forks or damage in one of the DNA strands.
Thus, Chk1 prevents cells from entering mitosis until nuclear DNA
replication is complete. Chk1 also blocks initiation of DNA repli-
cation in response to replication stress. Another closely related
protein kinase, Checkpoint kinase-2 (Chk2), prevents cells with
double strand breaks in their nuclear DNA from entering S phase,
a condition that would result in cell death.
THE FOUR PROTEIN KINASES THAT DRIVE THE MITOTIC CELL CYCLE
Of the eight protein kinases that directly link nuclear DNA repli-
cation to cell division (Figure 1A), only Cdk1 and Cdk2 exhibit
dramatic oscillations in their activity during continuous mitotic
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FIGURE 1 | Eight protein kinases regulate DNA replication in
mammalian cells. (A) Mitotic cell cycles produce one and only one copy of
the nuclear genome per cell division. Cdk7•CcnH activates Cdk1, Cdk2,
Cdk4, and Cdk6. Cdk4•CcnD and Cdk6•CcnD drives cells from a quiescent
state (G0) into a proliferative state. Cdk1•CcnB1 triggers mitosis.
Cdc7•Dbf4 and Cdk2•CcnE initiate DNA replication. Cdk2•CcnA2 prevents
DNA re-replication. Cdk1•CcnA2 prevents premature initiation during G2
phase. Chk1 inhibits Cdk1 and Cdk2 in response to either stalled replication
forks or DNA damage. Chk2 inhibits Cdc7 and Cdk2 in response to double
strand DNA breaks. (B) If proliferating cells attempt to re-replicate their
nuclear DNA before exiting the mitotic cell cycle, the result is a random
accumulation of partially re-replicated chromosomes that generates cells
with >4C but <8C DNA content that undergo apoptosis. (C) Endocycles
produce multiple copies of the nuclear genome in the absence of cell
division. In trophoblast giant cells, Cdk2 is essential for DNA replication in
the absence of Cdk1 activity, which is inhibited by p57, and Chk1 is
selectively suppressed. Cdc7 and Cdk7 are essential for initiation of preIC
assembly. Cdk4 and Cdk6 are assumed to be irrelevant.
cell cycles (Figure 2B). Changes in Cdk4 and Cdk6 activity are
dramatic only when cells transition from G0 to S phase and back
again. Nevertheless, the oscillations observed in the activities of
four CDK•cyclin protein complexes are sufficient to create a com-
puter model for the mitotic cell cycle in mammals (Gerard and
Goldbeter, 2009). These activities are linked together through a
succession of both positive and negative feedback loops that pro-
duce a self-sustained biochemical oscillator that drives the cell
cycle in one direction (Figure 3).
In response to a growth factor stimulus, cyclin D (CcnD) lev-
els increase and Cdk4•CcnD and Cdk6•CcnD drive the cell from
G0 to G1 phase by phosphorylating the retinoblastoma tumor
suppressor protein (Rb1). In this capacity, their activities are
redundant and therefore considered as a single CDK•cyclin activ-
ity. Since phosphorylated forms of Rb1 inhibit transcription factor
E2f, inactivation of Rb1 allows E2f to up-regulate expression of a
large number of gene activities that are required for DNA replica-
tion. Among these are cyclins E (CcnE), A (CcnA), and B (CcnB).
However, only CcnE accumulates during G1 phase, because the
anaphase-promoting complex (APC) associated with Cdh1, one of
the two APC regulatory subunits, ubiquitinates CcnA and CcnB,
thereby targeting them for degradation by the 26S proteasome
(reviewed in Pesin and Orr-Weaver, 2008). The APC•Cdh1 is
active only when Cdk1 and Cdk2 activities are suppressed (i.e.,
from anaphase in mitosis through G1 phase; Figure 2A).
Cell cycle dependent changes in the levels of cyclin proteins,
not their catalytic subunits, create corresponding changes in CDK
activities (Figure 2B) that drive the mitotic cell cycle. In response
to increasing levels of CcnE, Cdk2•CcnE activity drives the cell
from G1 into S phase (discussed below). In response to increas-
ing levels of cyclin A, Cdk2•CcnA phosphorylates and inactivates
CcnE by making it a target for the ubiquitin ligase CRL1•Skp2,
thereby inhibiting further activation of DNA replication com-
plexes at replication origins. Cdk2•CcnA also phosphorylates
and inactivates E2f, thereby down-regulating expression of genes
required for DNA replication, as well as several proteins that
are essential for assembly of prereplication complexes (preRCs),
thereby preventing re-licensing of replication origins during S
phase (discussed below). In response to increasing levels of CcnB, a
Cdk1•CcnB complex forms in the cytoplasm where it initiates con-
formational changes that allow Cdk1 to alter its phosphorylation
status and become an active kinase (reviewed in Pines, 2006). The
active Cdk1•CcnB complex then translocates to the nucleus where
it begins phosphorylating nuclear substrates that are necessary to
initiate mitosis.
The activities of each of these CDK•cyclin complexes are regu-
lated through positive feedback loops involving phosphorylation
and dephosphorylation by Cdc25, Wee1, and Myt1 (Figure 4). In
addition, negative feedback loops regulate Cdk1 and Cdk2 activ-
ities through APC ubiquitination of CcnA and CcnB (Figure 3).
However, during prometaphase, Cdc20 activates the APC, because
Cdc20 is active only when phosphorylated by either Cdk1 or Cdk2,
whereas Cdh1 is inactive when phosphorylated. During S and G2
phases, the APC-specific inhibitor Emi1 prevents phosphorylation
of Cdc20 by Cdk2, and Cdk2•CcnA phosphorylation of the APC
inhibits binding of Cdh1 to the APC and targets Cdh1 for ubiquiti-
nation by CRL1/SCF•Skp2 and subsequent degradation by the 26S
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FIGURE 2 |The activities of DDK, CDKs, and APC, and the level of the
CDK-specific inhibitor p27 oscillate during continuous proliferation of
human cells in culture. (A) Top panel relates changes in the activities of the
anaphase-promoting complex (APC, blue line), DDK (Dbf4-dependent Cdc7
kinase, green line), and total CDKs (red line) as a function of the phase of the
mitotic cell cycle. The cellular level of the CDK-specific inhibitor p27 (blue line)
parallels changes in APC activity. (B) Bottom panel relates the relative
changes that occur in the activities of Cdk1•CcnB (black), Cdk2•CcnE (red),
and Cdk2•CcnA (blue) as a function of the phase of the mitotic cell cycle.
These changes result from changes in the levels of the indicated cyclin
protein, not the CDK catalytic subunit. Cyclin expression is regulated through
cyclin stability rather than through transcription or translation (Morgan, 2007).
Cyclins are targeted for ubiquitin-dependent degradation by a series of
feedback loops involving CDKs and ubiquitin ligases whose activities are
themselves cell cycle dependent (Figure 3). As cells exit metaphase, the APC
targets CcnA and CcnB for ubiquitin-dependent degradation. Therefore, the
combined effects of the APC, p27, and the protein kinase Wee1 (not shown)
inactivate Cdk1, Cdk2, Cdk4, and Cdk6. PreRC assembly (Figure 5, top panel)
occurs only in the absence of CDK activity, the period encompassed by
anaphase, telophase, and G1 phase (Figure 2). PreIC assembly (Figure 5)
begins with the appearance of DDK and CDK activities in late G1 phase (A).
PreRC components are inactivated during S and G2 phases in order to
prevent DNA re-replication (Figure 6). The G1-Restriction Point occurs after
preRC assembly and before preIC assembly (Wu and Gilbert, 1997).
proteasome. Emi1 is selectively degraded during prometaphase. In
addition, both Cdk1 and Cdk2 (but not Cdk4 and Cdk6) are reg-
ulated through their reversible association with the CDK-specific
inhibitors Cdkn1a/p21/Cip1/and Cdkn1b/p27/Kip1, two proteins
whose activities also are regulated by feedback loops involv-
ing CDK-dependent phosphorylation and ubiquitin-dependent
degradation (reviewed in Guardavaccaro and Pagano, 2006). Cell
cycle dependent expression of both p21 and p27 follows that of
APC activity (Figure 2A). However, it is the CDK•cyclin network
itself that controls the balance between Rb1 and E2f through CDK-
dependent phosphorylation events, and it is this network alone
that can account for the periodic oscillations that drive the mitotic
cell cycle (Gerard and Goldbeter, 2011).
DNA RE-REPLICATION
DNA re-replication (Figure 1B) is an aberrant event that occurs
during mitotic cell cycles either when drugs are used to inter-
fere with DNA replication or mitosis, or when genes that regulate
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FIGURE 3 | Four CDK•cyclin activities regulate progress through
successive phases of the mitotic cell cycle (adapted from Gerard and
Goldbeter, 2009). Growth factors activate the synthesis of the transcription
factor Ap1, which promotes synthesis of CcnD, which forms a reversible
complex with Cdk4 and Cdk6 (Cdk4,6). The activity of Cdk4,6•CcnD, like that
of Cdk1 and Cdk2, is regulated by phosphorylation. Cdk4,6•CcnD
phosphorylates and thereby inactivates the retinoblastoma tumor suppressor
(Rb1). This phosphorylation allows activation of the transcription factor E2f.
The non-phosphorylated and monophosphorylated forms of Rb1 can form a
complex with E2f, thereby inhibiting its transcriptional activity. A second
phosphorylation of Rb1 by Cdk2•CcnE completely inhibits Rb1, thereby fully
activating E2f. E2f up-regulates the synthesis of CcnD, CcnE, and CcnA. CcnE
synthesis is induced by E2f and inhibited by Rb1-p and Rb1-pp. CcnE
reversibly forms a complex with Cdk2, the activity of which is regulated by
phosphorylation and dephosphorylation (Figure 3) and through association
with the CDK-specific inhibitors p21 and p27 (Figure 2A). As Cdk2•CcnE
accumulates, it phosphorylates p21 and p27, making them targets for
ubiquitination by CRL1•Skp2. Therefore, this phosphorylation event results in
ubiquitin-dependent degradation of p21 and p27 by the 26S proteasome.
Similarly, phosphorylation of CcnE by Cdk2•CcnA results in
ubiquitin-dependent degradation of CcnE by the 26S proteasome, thereby
ending the activation of preinitiation complexes at replication origins. As with
Cdk2•CcnE, Cdk2•CcnA is regulated by phosphorylation and
dephosphorylation (Figure 3) as well as by p21 and p27. Cdk2•CcnA controls
the S to G2 phase transition by eliciting the phosphorylation and subsequent
degradation of E2f. Both Cdk2•CcnA and Cdk1•CcnB phosphorylate and
thereby inhibit Cdh1, a protein that allows the APC ubiquitin ligase to target
cyclins A and B during the anaphase through G1 phase period when CDK
activity is low. This results in the accumulation of CcnA and CcnB. As
Cdk2•CcnA activity accumulates, it phosphorylates and thereby inhibits Cdh1,
thus leading to the eventual transition from G2 to M phase. CcnB reversibly
forms a complex with Cdk1, and Cdk1•CcnB also phosphorylates and inhibits
Cdh1, which amounts to a positive feedback loop for production of
Cdk1•CcnB. As with Cdk2•CcnE and Cdk2•CcnA, Cdk1•CcnB activity is
regulated by phosphorylation and dephosphorylation (Figure 3) as well as p21.
At its peak, Cdk1•CcnB activity initiates entry into mitosis. It also activates, by
phosphorylation, Cdc20, which creates a negative feedback loop wherein the
APC•Cdc20 targets CcnA and CcnB for ubiquitin-dependent degradation. As a
result, the levels of Cdk2•CcnA and Cdk1•CcnB activity decrease, thereby
allowing cells to complete mitosis and undergo cytokinesis. In the presence
of sufficient amounts of GF, cells spontaneously begin a new mitotic cell
cycle, corresponding to a new round of oscillations.
initiation of DNA replication are suppressed or over-expressed.
The result is a population of cells whose DNA content is >4C
but generally less than 8C. This excess DNA replication is a con-
sequence of incomplete chromosome reduplication that results
in stalled replication forks and DNA damage. Thus, instead of a
viable aneuploid cell, DNA re-replication results in DNA damage
and stalled replication forks that induce the cell’s DNA dam-
age response (activation of the ATR→Chk1→Cdc25 pathway;
Figure 4) and eventually apoptosis (Niida et al., 2005; Lin and
Dutta, 2007; Liu et al., 2007). DNA re-replication is prevented
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FIGURE 4 | Site specific phosphorylation and dephosphorylation events
regulate CDK•cyclin activity (reviewed in Domingo-Sananes et al., 2011).
Human CDK•cyclin complexes are maintained in an inactive state through
Wee1 phosphorylation of Tyr-15, and Myt1 phosphorylation of both Tyr-15 and
Thr-14 adjacent to the CDK catalytic site. For example, prophase begins when
the stockpile of Thr-14 and Tyr-15 phosphorylated Cdk1•CcnB is abruptly
activated by Cdc25-mediated dephosphorylation of Cdk1. As Cdk1•CcnB
activity appears, it catalyzes its own activation by two feedback loops. Wee1
is phosphorylated by Cdk1•CcnB, facilitating its degradation by the ubiquitin
ligases CRL1•βTrCP and CRL1•Tome1. Conversely, Cdc25 is activated by
multiple CDK phosphorylations. This allows Cdk1•CcnB to convert graded
inputs into switch-like, irreversible responses once a critical portion of the
enzyme becomes active. In mammalian cells, all three Cdc25 isoforms have
been implicated in cell cycle regulation. Cdc25A regulates both G1/S and S/G2
transitions, while Cdc25B and Cdc25C regulate late G2 and mitosis,
respectively (Lavecchia et al., 2010).
during mitotic cell cycles by the combined effects of Cdk2•CcnA,
CRL4•Cdt2, Geminin, and Chk1 (discussed below).
DEVELOPMENTALLY PROGRAMMED POLYPLOIDY
Remarkably, some cells are developmentally programmed to exit
their mitotic cell cycle in response to environmental signals and
then differentiate into non-proliferating, viable, polyploid cells.
This developmentally programmed polyploidy is a normal part of
animal and plant development that occurs frequently in ferns,
flowering plants, arthropods, fish, and salamanders, but rarely
in mammals. Developmentally programmed polyploidy occurs
by four different mechanisms (Ullah et al., 2009a; Lacroix and
Maddox, 2012). (1) “Acytokinetic mitosis” refers to cells that
become multinucleated by failing to undergo cytokinesis after
mitosis. Examples are proliferating cells in the syncytial blasto-
derm of Drosophila embryos, in hepatocytes in the postnatal liver
of mammals, and in cardiomyocytes proliferating during prena-
tal development. (2) “Cell fusion” refers to G1 phase cells that
fuse together to form multinucleated, terminally differentiated,
cells. Examples are differentiation of skeletal muscle myoblasts
into myotubes, monocytes into osteoclasts, and formation of pla-
cental syncytiotrophoblasts. (3) “Endomitosis” refers to cells that
exit their mitotic cell cycle during anaphase and then undergo
multiple S phases, each one terminated in anaphase. This results
in a cell with a single giant nucleus that may subsequently frag-
ment into a multinuclear appearance. Endomitosis occurs when
megakaryoblasts differentiate into megakaryocytes (Bluteau et al.,
2009), and in some plant cells (Weingartner et al., 2004). (4)
“Endoreplication” (Figure 1C) refers to cells that exit the mitotic
cell cycle during the G2 to M transition, conditions that allow
multiple rounds of nuclear genome duplication in the absence of
an intervening mitosis and cytokinesis (Edgar and Orr-Weaver,
2001; Lilly and Duronio, 2005; Lee et al., 2009). The result is a
non-proliferating cell undergoing an alternating sequence of S
and G phases, as outlined in Figure 8. Endoreplication is the pri-
mary mechanism for developmentally programmed polyploidy
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in arthropods, plants, differentiation of mammalian trophoblasts
into giant cells, and possibly stress induced polyploidy in car-
diomyoblasts, basal epithelial cells, and primitive podocytes. The
term endocycles refers to any cell undergoing multiple S phases
without completing mitosis.
ENDOREPLICATION
Endoreplication occurs in eukaryotes when cells exit their mitotic
cell cycle during the G2 to M phase transition, an event that can
be mimicked in yeast, flies, and mammals by inhibition of Cdk1
activity (Ullah et al., 2009b). Endoreplication is distinguished from
DNA re-replication in three ways. Developmentally programmed
polyploidy produces cells with >4C DNA content, but whose
DNA content is an integral multiple of 2C (e.g., 4C, 8C, 16C,
etc.), whereas DNA re-replication does not. Second, developmen-
tally programmed polyploidy produces terminally differentiated
cells that no longer proliferate, but remain viable. In contrast,
DNA re-replication results in cell death. Finally, developmen-
tally programmed polyploidy results in cells with either a single
giant nucleus or multiple nuclei of normal size, whereas DNA
re-replication produces cells with either an aneuploid nucleus or
micronuclei in a process termed “mitotic slippage” (Riffell et al.,
2009; Lee et al., 2010). Terminally differentiated polyploid cells
may serve to regulate tissue size or organization, to trigger cell
differentiation or morphogenesis, to increase the number of genes
dedicated to tissue specific functions without increasing the num-
ber of cells, or to adapt to environmental conditions. Nevertheless,
polyploidy is not always irreversible. Some polyploid cells in plants
and insects have been shown to reenter a mitotic cell cycle (Fox
et al., 2010), and DNA damaged polyploid cancer cells can reverse
to diploidy at a low frequency (Martin et al., 2009).
GENOME DUPLICATION
Although the mechanistic details of DNA replication are most well
documented in yeast and frog egg extracts, the fact that mammals
encode homologs or orthologs of each of the proteins required to
initiate nuclear DNA replication clearly supports an evolutionar-
ily conserved process that is essentially the same throughout the
eukarya (Table 1).
INITIATING NUCLEAR DNA REPLICATION
Initiation of DNA replication in eukaryotic cells involves a DNA
locus (the “replication origin”) at which a protein complex termed
the “preRC” is assembled and then subsequently converted into
a “preinitiation complex” (preIC). This last step permits DNA
unwinding which is linked to DNA synthesis of the new com-
plementary strands in both directions from the replication origin.
Assembly of preRCs on chromatin is referred to as “replication
licensing,” and the collection of proteins that carries out DNA
replication at a replication fork is termed the “replisome” (detailed
in DePamphilis and Bell, 2011).
Licensing of replication origins does not require a protein
kinase activity; on the contrary, preRC assembly occurs only
when CDK activity is suppressed (Schwob and Labib, 2006; Dif-
fley, 2011), an event that is restricted to the period from mitotic
anaphase until the G1 to S phase transition (Noguchi et al., 2006;
Baldinger and Gossen, 2009; Figure 2). Origin licensing begins
Table 1 | Proteins required for replisome assembly in eukaryotes.
S. cerevisiae Homo sapiens
PREREPLICATION COMPLEX
ORC(1–6) ORC(1–6)
Cdc6 Cdc6
Cdt1 Cdt1
Mcm(2–7) Mcm(2–7)
HBO1
PREINITIATION COMPLEX
Mcm(2–7) Mcm(2–7)
sCdc45 Cdc45
Sld3 Treslin
Sld2 RecQ4
Dpb11 TopBP1
GINS GINS
Pol-ε Pol-ε
Mcm10 Mcm10
RPA RPA
REPLISOME
Mcm(2–7) Mcm(2–7)
Cdc45 Cdc45
GINS GINS
Pol-ε Pol-ε
Mcm10 Mcm10
RPA RPA
Pol-α:primase Pol-α:primase
Pol-δ Pol-δ
with assembly of a DNA helicase loader onto the replication origin.
The DNA helicase loader consists of the six heterotypic subunits of
ORC(1–6), Cdc6, and Cdt1 (Sivaprasad et al., 2006; Diffley, 2011).
Orc1, ORC(2–5), and Orc6 are transported independently to the
nucleus where they assemble into a stable ORC(1–6) complex that
recruits Cdc6 and Cdt1 (Ghosh et al., 2011). This event is followed
by assembly of the six heterotypic subunits of the MCM helicase
[Mcm(2–7)] to form a “double hexamer” in which two MCM heli-
cases are loaded onto opposite strands of the DNA duplex. One
MCM helicase encompasses the “Watson” strand, and one encom-
passes the “Crick” strand. However, the MCM helicase remains
inactive at this step. Since inefficient origin licensing increases the
probability of stalled replication forks triggering a DNA damage
response and apoptosis, the mutations in Orc1, Orc4, Orc6, Cdt1,
and Cdc6 associated with individuals exhibiting microtia, patellar
aplasia/hypoplasia, and short stature (the Meier-Gorlin syndrome;
de Munnik et al., 2012) are the likely cause of this genetic defect.
Initiation of DNA replication is triggered by the Dbf4-
dependent Cdc7 kinase (DDK) followed by a CDK activity (Heller
et al., 2011) that converts the inactive MCM helicase in the preRC
into an active helicase that can unwind origin DNA (Figure 5;
Table 1). DNA unwinding is a prerequisite for DNA synthesis.
The critical step is formation of a Cdc45•MCM•GINS complex
that confers on the MCM helicase the ability to unwind the origin
DNA (Ilves et al., 2010; Labib, 2010). The transition from preRC
to replisome begins when DDK phosphorylates the Mcm4 and
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FIGURE 5 | Converting a preRC into two replisomes. In S. cerevisiae
(Heller et al., 2011), MCM/Mcm2-7 helicase is loaded onto origin DNA in
an inactive form during the anaphase to G1 phase transition of the mitotic
cell cycle to produce a prereplication complex. DDK (Cdc7•Dbf4 kinase)
phosphorylates the MCM helicase during the G1 to S phase transition,
thereby allowing recruitment of Sld3 and Cdc45 proteins. The S phase
CDK (Cdk1•Clb5 or Cdk1•Clb6) phosphorylates Sld2 and Sld3, thereby
triggering recruitment of Sld2, Dpb11, GINS, and Pol-ε. This event activates
the MCM helicase, which in the presence of the single-strand DNA
binding protein RPA, can unwind origin DNA. This event is followed by
recruitment of Mcm10 (not shown). The formation of a Cdc45-MCM-GINS
complex activates the helicase, which unwinds the DNA at the replication
origin. Pol-α:primase and Pol-δ are loaded onto the unwound DNA to
complete replisome assembly. Three genes have different names for the
human analog of the indicate yeast protein: Treslin/Sld3, RecQ4/Sld2, and
TopBP1/Dpb11.
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Mcm6 subunits of the MCM helicase (Randell et al., 2010; Sheu
and Stillman, 2010), two events that are essential for assembly of
Sld2 and Cdc45 proteins onto the preRC. The next step requires the
phosphorylation of Sld2 and Sld3 by a CDK activity (Tanaka et al.,
2007; Zegerman and Diffley, 2007). Single cell eukarya such as
yeast use their only CDK (Cdk1) together with an S phase cyclin to
carry out this step, whereas multicellular eukarya use Cdk2•CcnE.
The phosphorylated forms of Sld2 and Sld3 bind Dpb11 pro-
tein, and the Sld2•Sld3•Dpb11 complex allows recruitment of the
heterotypic four-subunit GINS complex. This event is essential
for subsequent recruitment of Pol-ε, the DNA polymerase that
extends the RNA-primed nascent DNA strand that initiates DNA
synthesis on the leading strand template (Muramatsu et al., 2010).
This protein complex constitutes a preIC with an active MCM heli-
case. The single-strand DNA binding protein RPA also is required
to facilitate DNA unwinding. Finally, two active replisomes form
upon addition of Pol-α:primase (the DNA polymerase that initi-
ates RNA-primed DNA synthesis) and Pol-δ (the DNA polymerase
that extends nascent RNA-p-DNA strands on the lagging strand
template). One difference between S. cerevisiae and vertebrates
appears to be the role of Mcm10. In S. cerevisiae, Mcm10 is essen-
tial for the final step of loading Pol-α:primase and Pol-δ, whereas
in Xenopus egg extracts, Mcm10 is essential for loading Cdc45. In
both cases, Mcm10 stabilizes the final replisome structure.
PREVENTING DNA RE-REPLICATION
Restricting genome duplication to once per cell division requires
that cells do not reinitiate nuclear DNA replication within regions
that have already been replicated until cell division is completed.
Mammalian cells accomplish this through multiple concerted
pathways (Figure 6; DePamphilis et al., 2006; Arias and Walter,
2007). As mammalian cells enter S phase, each DNA replication
bubble contains ORC, Cdc6, and Cdt1 bound to one copy of
the replication origin, whereas the other copy does not. In addi-
tion, many preRCs are found at dormant replication origins that
are activated only under conditions of replication stress, such as
reduction of dNTP pools (Blow et al., 2011). Therefore, to prevent
reinitiation of nuclear DNA replication, the cell must inactivate
both bound and unbound preRC proteins.
The first line of defense is Cdk2•CcnA. This protein kinase
phosphorylates Orc1, Cdc6, and Cdt1, thereby suppressing their
activities and preventing their participation in further initiation
events. Phosphorylated Cdc6 (Cdc6-P) is localized to the cyto-
plasm where it cannot participate in origin licensing. The ubiquitin
ligase CRL1/SCF•Skp2 targets Orc1-P and Cdt1-P for export to
the cytoplasm where they are degraded by the 26S proteasome
(Saxena and Dutta, 2005; Saha et al., 2006). Orc1 inactivation
is followed by subsequent release of the other ORC subunits
(Siddiqui and Stillman, 2007). Only the Orc1, Orc2, and Orc6
subunits contain potential CDK phosphorylation sites, and CDK-
dependent phosphorylation of Orc2 destabilizes the remaining
ORC subunits (Lee et al., 2012b). This S phase dependent release
of ORC(1–6) from chromatin occurs also in flies, frogs, and worms
(Rowles et al., 1999; Sun et al., 2002; Remus et al., 2005; Sonneville
et al., 2012). In addition, CRL4•Cdt2 inactivates preRCs associ-
ated with chromatin by ubiquitinating non-phosphorylated Cdt1
that is bound to both PCNA and DNA (Havens and Walter, 2011).
Degradation of Cdt1 by CRL4•Cdt2 occurs in fungi and meta-
zoa, whereas CRL1•Skp2 mediated Cdt1 degradation has been
demonstrated only in humans; the pathway is not conserved in
yeast, invertebrates, or even among other vertebrates (Kim and
Kipreos, 2007).
As cells enter G2 and M phases, preRC proteins are again
expressed but in modified forms that both suppress their activ-
ity and prevent their destruction. The largest ORC subunit, Orc1,
is hyperphosphorylated by Cdk1•CcnA (Li et al., 2004) and trans-
ported to the cytoplasm (Saha et al., 2006). Thus, CDK dependent
phosphorylation prevents both Orc1 and Cdc6 from initiating
preRC assembly until cells exit metaphase. Moreover, phospho-
rylation protects Cdc6 from being targeted for degradation by
the APC (Mailand and Diffley, 2005). The same may be true
for other preRC components. Geminin binds to and inactivates
Cdt1, thereby preventing it from loading MCM helicases onto
ORC•Cdc6•chromatin sites during the G2 to M phase transi-
tion (Klotz-Noack et al., 2012). As with phosphorylation of Cdc6,
Geminin also protects Cdt1 from ubiquitin-mediated degradation
(Ballabeni et al., 2004). As cells exit metaphase, Cdc14 phos-
phatase dephosphorylates the ORC subunits and Cdc6, making
them available for preRC assembly in the absence of CDK activity
(Zhai et al., 2010). Geminin is targeted by the APC for ubiquitin-
mediated degradation, thereby making Cdt1 immediately available
to complete preRC assembly by recruiting the MCM helicase.
In addition to these safeguards, DNA replication stress, such
as reduction of dNTP pools, activates the DNA replication check-
point pathway. The effector kinase of this pathway, Chk1, inhibits
activation of preRCs in two ways: Chk1 inhibits Cdc25 phos-
phatases by phosphorylating them at specific sites, thereby pre-
venting activation of Cdk2 and Cdk1 (Figure 4; reviewed in Chen
and Poon, 2008). This prevents activation of preRCs, because
Cdk1 is the only CDK that can substitute for Cdk2 in reg-
ulating S phase (discussed below). Chk1 also phosphorylates
Treslin/Sld3, thereby preventing the interaction between Tres-
lin/Sld3 and TopBP1/Dpb11. This prevents formation of the
Cdc45•MCM•GINS complex that is essential for migration of
replication forks (Boos et al., 2011).
INDUCING DNA RE-REPLICATION SELECTIVELY KILLS CANCER CELLS
Of the eight pathways that prevent DNA re-replication (Figure 6),
six are CcnA dependent, one is Geminin dependent, and one
is CRL4 dependent. Suppressing expression of CcnA or CRL4
activity with siRNAs can induce marginal amounts of DNA re-
replication in human cells derived from either normal or cancer
tissues (Lovejoy et al., 2006; Machida and Dutta, 2007; Zhu and
Depamphilis, 2009). However, human cancer cells are far more
dependent than normal cells on Geminin to regulate origin licens-
ing (Zhu and Depamphilis, 2009). Suppression of Geminin alone
is sufficient to induce extensive DNA re-replication in cells derived
from human cancers, but not in cells derived from normal tissues.
Inducing extensive DNA re-replication in cells derived from nor-
mal tissues requires suppression of both CcnA and Geminin. This
distinction might account for the genetic instability commonly
seen in cancer cells as a consequence of inadequate regulation of
origin licensing, which leads either to under- or over-replication
of chromosomal DNA (Blow and Gillespie, 2008). Suppression
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FIGURE 6 | Multiple concerted pathways prevent DNA re-replication in
mammals. Once mammalian cells have entered S phase, re-replication of
DNA that has already been replicated is prevented by inactivation of Orc1,
Cdc6, and Cdt1 by direct Cdk2•CcnA dependent phosphorylation. In addition,
Cdc6-P is localized to the cytoplasm, and both Orc1-P and Cdt1-P are
substrates for the ubiquitin ligase CRL1•Skp2. Cdt1 that is not
phosphorylated, but associated with PCNA and DNA, is targeted for
degradation by the CRL4•Cdt2 ubiquitin ligase. PCNA is the eukaryotic sliding
clamp protein that allows DNA polymerases-δ and -γ to synthesize DNA
continuously without falling off the primer–template. Binding of Geminin also
inhibits Cdt1, and Orc1 is also inhibited directly by Cdk1•CcnA
phosphorylation, events that are required during G2 and early M phase.
of Gmnn expression by siRNA in cells derived from a variety
of carcinomas, adenocarcinomas, glioblastomas, and osteosarco-
mas induces DNA re-replication, DNA damage, a DNA damage
response, and finally apoptosis (Melixetian et al., 2004; Zhu et al.,
2004; Tachibana et al., 2005; Zhu and Dutta, 2006), whereas under
the same conditions, suppression of Geminin in cells derived
from normal human tissues does not prevent their continued
proliferation (Zhu and Depamphilis, 2009). This distinction is
not an experimental artifact, because DNA re-replication could
be induced in normal cells if both Geminin and CcnA expres-
sion are suppressed, either directly with individual siRNAs (Zhu
and Depamphilis, 2009), or indirectly by suppressing expression
of Emi1 (Di Fiore and Pines, 2007; Machida and Dutta, 2007;
Lee et al., 2012a). Emi1 binds to and inhibits the APC during S,
G2, and early M phases, thereby preventing premature activation
of the APC with concomitant destruction of CcnA, CcnB, and
Geminin. Therefore, in many cancer cells, Geminin is essential to
prevent DNA re-replication, whereas in normal cells, both Gem-
inin and one or more of the CcnA dependent pathways prevent
DNA re-replication (Figure 6). Thus, suppressing Geminin activ-
ity in humans could selectively kill a variety of different cancer
cells with little or no effect on proliferation of non-cancerous tis-
sues. Candidates for such drugs are currently being identified by
high throughput screens of small molecules for compounds that
mimic the effects of siRNA against Geminin on human cells (Zhu
et al., 2011; Lee et al., 2012a).
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HOW PROTEIN KINASES CONTROL DNA REPLICATION
The eight protein kinases that directly control DNA replication
during cell division can be classified into three groups: Dbf4-
dependent proteins kinases, CDKs, and checkpoint kinases. What
exactly do these proteins do?
THE ROLE OF DDK ENZYMES
The Dbf4-dependent protein kinases are composed of a cat-
alytic subunit (Cdc7) and a regulatory subunit (Dbf4 or Drf1).
DDK is involved in replisome assembly, loading of cohesins onto
chromatin, phosphorylation of the checkpoint mediator protein
claspin, and the activation of the ATR–Chk1–Cdc25 DNA repli-
cation checkpoint (Swords et al., 2010). Not surprisingly, Cdc7 is
required for normal mouse development. Studies in yeast and in
frog egg extracts suggest that DDK is recruited to replication ori-
gins by the MCM helicase where it promotes the stable formation
of the Cdc45•MCM helicase complex by phosphorylating each of
the subunits in the MCM helicase, except for Mcm5 (Labib, 2010;
Sheu and Stillman, 2010; Heller et al., 2011).
THE ROLE OF CDK ENZYMES
As with DDK enzymes, the cyclin-dependent protein kinases con-
sist of a catalytic subunit (Cdk) and a regulatory subunit (cyclin)
that is essential for CDK activity and target specificity. In yeast,
a single Cdk subunit (termed either Cdk1, Cdc28, or Cdc2) reg-
ulates cell division by pairing with five to seven different cyclin
subunits. The human genome encodes 13 different Cdk subunits,
of which 11 have been characterized, and 25 cyclins, of which 19
have been characterized. However, only Cdk1, Cdk2, Cdk4, and
Cdk6 are involved directly in driving the mitotic cell cycle. They
are activated by only 10 different cyclins from four gene fami-
lies: cyclins A, B, D, and E. However, these CDK•cyclin complexes
are not active unless the Cdk subunit is phosphorylated at a spe-
cific site by Cdk7•CcnH. Remarkably, not all of these proteins are
essential for mammalian development, as other members of the
Cdk and cyclin families can play some of their roles.
Studies with frog egg extracts and mammalian cells make a
compelling case that Cdk2 is required to initiate and regulate S
phase in multicellular eukaryotes (see Berthet et al., 2003; Ortega
et al., 2003). However, Cdk2 is dispensable for the regulation of
mitotic cell cycles in mice as long as both Cdk1 and Cdk4 are
available (reviewed in Satyanarayana and Kaldis, 2009). As with
yeast, Cdk1 alone can drive the mammalian cell cycle, by replacing
Cdk2 in the initiation and regulation of S phase. Other than Cdk1,
ablation of individual mouse CDKs has little effect on cell cycle
progression and mouse embryonic development (Table 2). Mouse
embryos lacking Cdk2, Cdk3, Cdk4, or Cdk6 develop into viable
adults with only mild delays in cell cycle progression. Deletion
of both Cdk4 and Cdk6 do not significantly affect mouse devel-
opment or proliferation of mouse embryonic fibroblasts. Even
simultaneous deletion of Cdk2, Cdk4, and Cdk6 allows embryos
to develop up to midgestation (gestation occurs from 19 to 21 days
after fertilization), and embryonic fibroblasts lacking Cdks 2, 4,
and 6 still proliferate, although more slowly, and still develop into
immortalized cell lines. Thus, Cdk1 alone can substitute for Cdks
2, 4, and 6 through trillions of cell divisions. At that point, a spe-
cific requirement of either Cdk4 or Cdk6 for hematopoiesis results
in embryonic death due to anemia. Clearly, the mitotic cell cycle
is highly conserved throughout the eukarya, and the multitude of
CDKs encoded by mammals evolved to carry out specific tasks
required in the development of complex multicellular organisms.
The CDK regulatory subunits also exhibit functional redun-
dancy. As with Cdk4 and Cdk6, ablation of any one of their cyclin
partners (the CcnD1, CcnD2, or CcnD3 gene) does not affect
mouse development, viability, or fertility (Table 3). Therefore,
Cdk4 and Cdk6 can use any one of the three cyclin D proteins.
Ablation of all three cyclin D genes also does not affect the ability
of mouse embryonic fibroblasts to proliferate, thereby confirm-
ing that the functions of Cdk4•CcnD and Cdk6•CcnD are not
essential for cell proliferation. However, mouse embryos lacking
all three cyclin D genes die at E16.5 due to proliferative defects in
hematopoietic cells and cardiac myocytes (Table 3), which reveals
that the role of these enzymes is required for specific developmen-
tal events. That role may reside in the “G1 restriction point” that
prevents preRCs from becoming preICs in the absence of nutri-
ents or mitogens (Figure 2A; DePamphilis and Bell, 2011). The
G1 restriction point marks the transition from an inactive form
of the transcription factor E2f (the E2f•Rb complex) to an active
Table 2 | Effect of CDK deletions on mouse development.
Deletion Phenotype Reference
Cdk1 Embryonic lethality during first cell divisions Santamaria et al. (2007)
Cdk2 Reduced body size, impaired neural progenitor cell proliferation, infertility in
males and females
Berthet et al. (2003), Ortega et al. (2003)
Cdk3 Viable and fertile Ye et al. (2001)
Cdk4 Reduced body size, insulin deficient diabetes, infertility in males and females Rane et al. (1999), Tsutsui et al. (1999)
Cdk5 Death at birth, severe neurological defects Ohshima et al. (1996)
Cdk6 Fertile hypoplasia of thymus and spleen, defects in hematopoiesis Malumbres et al. (2004)
Cdk4+Cdk6 Lethality between embryonic day E14.5 and birth. Defective hematopoiesis,
MEFs are viable
Malumbres et al. (2004)
Cdk2+Cdk4 Lethality between E14.5 and E16.5, cardiac and hematopoietic abnormalities Berthet et al. (2006)
Cdk2+Cdk6 Infertility in males and females, defective hematopoiesis Malumbres et al. (2004)
Cdk2+Cdk4+Cdk6 Lethality by E13.5 due to hematopoietic defects. MEFs proliferate slowly, but
become immortal
Santamaria et al. (2007)
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Table 3 | Effect of cyclin deletions on mouse development.
Deletion Phenotype Reference
CcnA1 Viable, infertile males Liu et al. (1998)
CcnA2 Death by E5.5 Murphy et al. (1997),
Kalaszczynska et al. (2009)
CcnB1 Death by E10.5 Brandeis et al. (1998)
CcnB2 Viable and fertile Brandeis et al. (1998),
Draviam et al. (2001)
CcnD1 or D2 or D3 Viable and fertile Ciemerych et al. (2002)
CcnD1+D2+D3 Death by E16.5,
proliferative defects in
hematopoietic cells and
cardiac myocytes,
viable MEFs
Kozar et al. (2004)
CcnE1 or E2 Viable and fertile Geng et al. (2003), Parisi
et al. (2003)CcnE1+E2 Late embryonic death,
rescued using wild-type
placenta, no TG
endoreplication, viable
MEFs
form of E2f. This transition occurs when Rb1 is phosphorylated by
Cdk4,6•CcnD (Figure 3). E2f then activates transcription of genes
such as CcnE that are required to initiate and maintain S phase.
Both Cdk4,6•CcnD and Cdk2•CcnE inactivate the CDK-specific
inhibitor p27 whose role is to prevent premature entrance into S
phase (Figure 2A), although by totally different mechanisms.
The requirement for cyclin E follows a pattern similar to that for
cyclin D. Ablation of either CcnE1 or CcnE2 does not interfere with
normal embryo development, although ablation of both CcnE1
and CcnE2 results in late embryonic death (Geng et al., 2003;
Parisi et al., 2003). Death, however, does not result from a failure in
mitotic cycles, but from defects in placentation and hematopoiesis.
Mouse embryonic fibroblasts that lack CcnE are viable, but endo-
cycles in trophoblast giant (TG) cells and megakaryocytes are
severely impaired in the absence of CcnE.
Mammals have two A-type cyclins and two B-type cyclins,
but only CcnA2 and CcnB1 are essential for mouse development
(Table 3). Cdk2•CcnA2 prevents DNA re-replication during S
phase (Figure 6). Cdk1•CcnA2 not only phosphorylates ORC
subunits during the G2 to M phase transition (Li et al., 2004), but
phosphorylates histone H3 as cells enter prophase, thereby facili-
tating chromatin condensation (Gong and Ferrell, 2010). CcnA2
also is required for the activation and nuclear localization of
Cdk1•CcnB1. CcnB2 is restricted to reorganizing the Golgi appa-
ratus at mitosis, but Cdk1•CcnB1 is the primary force that drives
cells from G2 into mitosis (Brandeis et al., 1998; Draviam et al.,
2001). Not surprisingly, Cdk1•CcnB1 activity is carefully regu-
lated. Once cyclin B binds to Cdk1, the complex is inactivated by
Wee1, a protein kinase that phosphorylates T14 and Y15 in human
Cdk1 (Morgan, 2007). Then, in G2 phase human cells, Cdc25
phosphatase converts Cdk1•CcnB1 from an inactive form to an
active form, thereby initiating prophase (Gavet and Pines, 2010).
For example, Cdk1•CcnB1 phosphorylates the nuclear lamina,
triggering breakdown of the nuclear envelope. Cdk1•CcnB1 levels
rise to their maximum extent over the course of approximately
30 min, with different levels of CDK kinase activity triggering dif-
ferent mitotic events by selectively phosphorylating a large number
of substrates, including the APC.
Before Cdk1, Cdk2, Cdk4, or Cdk6 can form a stable
CDK•cyclin complex, the CDK catalytic subunit must be acti-
vated by the “CDK-activating kinase.” In flies and vertebrates, this
kinase is a complex of Cdk7, cyclin H (CcnH), and Mat1 (Merrick
et al., 2008). Mat1 is required only in activating RNA polymerase
(Patel and Simon, 2010). Cdk7•CcnH activates the CDK catalytic
subunit by phosphorylating threonine residue 160 in the CDK
activation loop. This phosphorylation stabilizes the CDK•cyclin
complex. Thus, the ability of these four CDKs to function depends
on when during the mitotic cell cycle this activation step occurs. In
mammalian cells, Cdk7•CcnH phosphorylates Cdk2 before Cdk2
binds a cyclin. This means that Cdk2 forms an active kinase as
soon as a cyclin is available. In contrast, Cdk7•CcnH phosphory-
lates Cdk1 only after it binds a cyclin. Since Cdk1•cyclin complexes
are unstable until after Cdk7•CcnH has phosphorylated them, this
means that active Cdk1•cyclin complexes cannot form until the
concentration of cyclin is great enough for mass action to produce
significant amounts of Cdk1•cyclin complex. The competitive
advantage for cyclin partners enjoyed by Cdk2 means that even
though Cdk1 is ∼10-fold more abundant than Cdk2 in human
cells, the appearance of CcnA would strongly favor formation of
active Cdk2•CcnA enzyme over active Cdk1•CcnA enzyme.
THE ROLE OF CHECKPOINT KINASES
The two remaining kinases directly involved in regulation of
nuclear DNA replication in mammals are the two closely related
checkpoint kinases: Chk1 and Chk2 (reviewed in Chen and Poon,
2008). They are part of the DNA damage response pathway that
prevents cells from entering mitosis until they have completed
genome duplication. Chk2 is the effector kinase in the Atm–Chk2–
Cdc25 pathway that senses double strand DNA breaks (Reinhardt
and Yaffe, 2009). Chk2−/− mice are viable and fertile, although
sensitive to ionizing radiation (Takai et al., 2002). Therefore, Chk2
is not an essential gene in mammals, apparently because Chk1 can
substitute for Chk2.
Checkpoint kinase-1 is essential for mammalian cell prolifer-
ation and embryonic development (Liu et al., 2000; Lam et al.,
2004; Niida et al., 2005; Tang et al., 2006). It is the effector kinase
in the Atr–Chk1-Cdc25 DNA damage checkpoint pathway that
senses RPA bound to single-strand DNA breaks, bulky lesions, and
stalled replication forks (Smits et al., 2010). The ataxia telangiec-
tasia and Rad3-related (Atr) protein kinase activates Chk1, which
then inhibits origin firing (Smits et al., 2010). At low levels of
replication stress, Chk1 suppresses origin initiation predominantly
by inhibiting the activation of new replication factories (clusters
of replisomes identified as replication foci), thereby reducing the
number of active factories (Ge and Blow, 2010). At the same time,
inhibition of replication fork progression allows dormant origins
to initiate within existing replication factories. The checkpoint
mediator protein Claspin facilitates the phosphorylation and acti-
vation of Chk1 by ATR and therefore is also required for efficient
DNA replication. Claspin and Chk1 regulate fork stability and
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fork density in unperturbed cells as well as in cells suffering from
induced DNA damage. However, whereas Chk1 regulates origin
firing predominantly by controlling activation of Cdk2 by Cdc25
phosphatase (Figure 4), Claspin plays a role in regulating replica-
tion fork stability that is independent of its function in mediating
Chk1 phosphorylation (Scorah and McGowan, 2009). The abil-
ity of Chk1 to promote replication fork progression on damaged
DNA templates relies on its recently identified proliferating cell
nuclear antigen-interacting motif, which is required for its release
from chromatin after DNA damage (Speroni et al., 2012). Only
then is Chk1 kinase activity and interaction with Claspin required
for the DNA damage response.
INITIATING ENDOREPLICATION
The paradigm for endoreplication in mammals is the differen-
tiation of trophoblast stem (TS) cells into TG cells, an example
of developmentally programmed polyploidy in which the DNA
content of TG cells in vivo can reach >1000C, although TG cells
generated in vitro seldom exceed 64C (Hu and Cross, 2010). TS
cells are derived from the trophectoderm of blastocysts, the outer
layer of epithelial cells that give rise exclusively to the various
cells comprising the placenta. When re-established in a blastocyst,
TS cells contribute exclusively to the placenta, giving rise to all
of the cell lineages derived from the trophectoderm (Oda et al.,
2010). When cultured in vitro, TS cells proliferate in the presence
of fibroblast growth factor-4 (FGF4) and conditioned medium,
but in the absence of these mitogens, they differentiate into the
TG cells essential for implantation and placentation.
Based on studies of mouse TS and TG cells as well as mouse
placentation, a mechanism has emerged that is consistent with
studies of endoreplication in flies (Ullah et al., 2009b). Cells exit
the mitotic cell cycle during the G2 to M phase transition when one
S phase has been completed, but the nuclear membrane remains
intact and the chromosomes have not undergone condensation.
Exit is achieved by inhibiting Cdk1 activity. In mammals, this is
accomplished by expression of Cdkn1c/p57/Kip2 (p57) and p21,
two CDK-specific inhibitors that are unique to mammals. In flies
the same event is accomplished by down-regulating the mitotic
activators stg/cdc25, cyclin A and cyclin B as well as up-regulating
Dacapo, their only CDK-specific inhibitor.
The critical event in the transition from mitotic cell cycles
to endoreplication in both flies and mammals is the switch
from a CDK-dependent form of the “APC” (APC•Cdc20/Fzy)
to one that functions only in the absence of CDK activity
(APC•Cdh1/Fzr; Ullah et al., 2009b). Cdc20 and Cdh1 are the
mammalian homologs of the Drosophila Fzy and Fzr proteins,
respectively. Both APCs ubiquitinate cyclin A, cyclin B, and Gemi-
nin, thereby targeting them for degradation by the 26S proteasome,
but neither ubiquitinates cyclin E. Since cyclins A and B promote
mitosis, and cyclin A and Geminin prevent preRC assembly, inac-
tivation of these proteins promotes the transition from mitosis to
G1 phase. This allows replication licensing to occur again without
the cell passing through mitosis, and the subsequent rise in cyclin
E to activate preIC assembly and trigger a second S phase.
Multiple S phases increase the probability of stalled replica-
tion forks and DNA damage, but in flies cells programmed to
endoreplicate their genomes do not undergo apoptosis when DNA
re-replication is induced by over-expression of Cdt1, whereas cells
undergoing mitotic cell division do (Mehrotra et al., 2008). In
mouse TG cells, apoptosis due to endocycle induced DNA replica-
tion stress appears to be suppressed by the absence of Chk1 protein
and the expression of the CDK-specific inhibitor p21.
THE ROLE OF p57
Selective inhibition of Cdk1 induces endoreplication in a variety of
cells, including those from yeast, flies, birds, and mammals (Ullah
et al., 2009b). RO3306 is a drug that can selectively inhibit Cdk1
activity in mammalian cells; thereby arresting them during the
G2 to M phase transition and inducing endoreplication in some,
but not all, cell types (Vassilev et al., 2006; Ullah et al., 2008; Ma
et al., 2009). These differences likely reflect the fact that selec-
tive inhibition of Cdk1 activity reversibly arrests cells in G2 phase
without inducing endoreplication, whereas cells arrested during
prometaphase endoreplicate, because the loss of Cdk1 activity
activates the APC which then targets Gmnn, CcnA, and CcnB
for degradation (Hochegger et al., 2007). Selective inhibition of
Cdk1 by RO3306 in proliferating TS cells not only initiates up to
five endocycles, but it also induces differentiation into TG cells.
In contrast, the same treatment induces abortive endoreplication
and apoptosis in ES cells. Thus, TG cells are unique in that they
differentiate into viable, polyploid, non-proliferating cells under
conditions in which cells that are not programmed for terminal
differentiation undergo apoptosis.
How is Cdk1 activity in TS cells inhibited in vivo? FGF4-
deprivation of TS cells results in a rapid decrease in Cdk1 activity
that cannot be accounted for by corresponding changes in the pro-
tein levels of Cdk1 or cyclins A, B, or E (Ullah et al., 2008). The
loss of Cdk1 activity is accompanied by a concomitant increase in
the expression of p57 and p21, two CDK-specific inhibitors that
target Cdk1 and Cdk2 (Ullah et al., 2008). Both p57 and p21 are
unique to mammals, and one or both are expressed in all termi-
nally differentiated cells (Ullah et al., 2009a). Expression levels for
the third member of this gene family, p27, remain constant dur-
ing differentiation, presumably because p27 and its orthologs in
other eukarya prevent premature entrance into S phase during
both mitotic cell cycles and endocycles (Pagano, 2004). In TS cells,
the role of RO3306 is played by p57, which is essential for switch-
ing from mitotic cell cycles to endocycles. FGF4-deprivation of
TS(p57−/−) cells results in several rounds of cell division followed
by formation of multinucleated TG cells. Thus, in the absence of
p57, loss of the mitogenic stimulus induces differentiation into TG
cells in which mitosis can continue in the absence of cytokinesis.
This could account for the observed correlation between reduced
p57 expression, placentamegaly, and preeclampsia in both mice
and humans (Knox and Baker, 2007; Ullah et al., 2008).
THE ROLE OF Chk1
What links FGF4-deprivation to expression of p57 and p21? Recent
studies have revealed that the p21, p27, and p57 genes are tran-
scribed and translated in proliferating TS cells, but p21 and p57
proteins are phosphorylated, thereby selectively targeting them for
degradation by the 26S proteasome (Ullah et al., 2011). Remark-
ably, Chk1, the same protein kinase that prevents cells from enter-
ing mitosis before the completion of S phase, also prevents TS
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cells from premature differentiation into TG cells. Chk2 cannot
substitute for Chk1 in suppressing expression of the p57 and p21
genes.
Fibroblast growth factor-4-deprivation of TS cells selectively
suppresses expression of Chk1 protein with concomitant induc-
tion of both p57 and p21 proteins and differentiation of TS cells
into TG cells. These two events are linked directly, because either
siRNA suppression of Chk1 protein expression, or chemical inhi-
bition of Chk1 kinase activity in proliferating TS cells induces
expression of p57 and p21 proteins (Ullah et al., 2011). Conversely,
ectopic expression of Chk1 kinase activity in TG cells suppresses
expression of p57 during G phase, thereby restoring mitosis – but
not cytokinesis – and the appearance of multinucleated cells. The
mechanism by which Chk1 expression is suppressed in response to
FGF4-deprivation of TS cells remains to be elucidated, although it
likely involves one of the ubiquitin ligases that target this enzyme
(Leung-Pineda et al., 2009; Zhang et al., 2009).
Thus, in the absence of induced DNA damage, Chk1 serves as
a mitogen-dependent protein kinase that prevents proliferating
TS cells from exiting their mitotic cell cycle and differentiat-
ing into TG cells. This means that the same effector kinase that
arrests cell proliferation in response to DNA damage and stalled
replication forks (“DNA Replication Checkpoint”) prevents the
arrest of cell proliferation during the G2 to M phase transition
in the absence of induced DNA damage (“G2 Restriction Point,”
Figure 7). Small wonder then that the Chk1 gene is essential
for cell proliferation, and that Chk1 deficiency results in peri-
implantation embryonic lethality (Liu et al., 2000; Lam et al.,
2004; Niida et al., 2005; Tang et al., 2006). Moreover, since the
ability of Chk1 to prevent p57 expression is not restricted to TS
cells, the G2 Restriction Point presumably exists in all cells that
are developmentally programmed for terminal differentiation by
up-regulating either p57 or p21. Hence, pluripotent cells in preim-
plantation embryos can transcribe their p57 and p21 genes as soon
as the trophectoderm lineage is specified at the eight-cell stage
(Yagi et al., 2007), but Chk1 prevents their differentiation into giant
cells until the mural trophectoderm is deprived of FGF4 during the
peri-implantation period. The G2 restriction point likely operates
throughout mammalian development to prevent premature cell
cycle exit in progenitor cells destined for terminal differentiation.
In contrast to TS cells, suppressing Chk1 activity in cells that
do not express their p57 gene results in apoptosis, a conse-
quence of mitotic catastrophe due to accumulated DNA damage
and stalled replication forks. Similarly, ablation of the p57 gene
in mice delays differentiation during mouse development and
increases the frequency of apoptosis (Yan et al., 1997; Zhang et al.,
1997). Cells with DNA damage or incomplete genome duplica-
tion cannot proceed into mitosis without inducing apoptosis. The
Chk1-dependent phosphorylation of Cdc25 prevents mitotic cat-
astrophe during cell proliferation. However, by preventing mitosis
in TG cells with p57 and the eventual loss of Cdk1, suppression
of Chk1 disrupts the link between the DNA damage response and
apoptosis.
THE ROLE OF p21
Late replicating heterochromatic sequences in Drosophila are
under-represented in polyploid cells, apparently because they lack
a cell cycle checkpoint for detecting stalled replication forks and
DNA damage (Lilly and Spradling, 1996). Similar mechanisms
presumably operate in mammals, as well. Although p21 is not
essential for either cell proliferation or viability, mammalian cells
lacking p21 fail to arrest in G1 phase in response to induced DNA
damage (Brugarolas et al., 1995; Deng et al., 1995). In addition to
direct inhibition of Cdk1 activity (Satyanarayana et al., 2008), p21
participates in the maintenance of G2 arrest after DNA damage
by down-regulating Emi1 in cells that have initiated transient G2
arrest through the ATM/ATR pathway (Lee et al., 2009; Figure 7).
Therefore, low levels of p21 may be sufficient to facilitate mitotic
cell cycles, whereas high levels of p21 may facilitate terminal cell
differentiation by suppressing apoptosis (Ullah et al., 2008). The
p21 protein also may act as a feedback loop in the G2 restriction
point by suppressing expression of Chk1 (Figure 7). As the level
of Chk1 protein diminishes during FGF4-deprivation, the level of
p21 increases, and this increase in p21 can further reduce Chk1
mRNA levels (Gottifredi et al., 2001).
SUSTAINING ENDOREPLICATION (ENDOCYCLES)
Once cells exit the mitotic cell cycle and initiate either endorepli-
cation or endomitosis, they are capable of undergoing several
additional S phases in the absence of an intervening mitosis,
cytokinesis, or apoptosis. How are these multiple S phases in the
absence of cell division (termed “endocycles”) sustained?
THE REQUIREMENT FOR Cdk2 AND CYCLIN E
In vertebrates, either Cdk2 or Cdk1 is essential to initiate S phase
during mitotic cell cycles, but Cdk2 is essential for endoreplication
in TG cells, because Cdk1 activity is selectively suppressed (Ullah
et al., 2008). Chemical inhibition of both Cdk2 and Cdk1 prevents
both TS cell proliferation and differentiation, whereas selective
inhibition of Cdk1 prevents proliferation and triggers differenti-
ation. However, Cdk2−/− TS cells fail to endoreduplicate when
Cdk1 is selectively inhibited by RO3306, whereas they endoredu-
plicate and differentiate into TG cells when deprived of FGF4.
Therefore, p57 levels in TG cells must oscillate in order to allow
preRC assembly during G phase followed by CDK-dependent ini-
tiation of S phase. In fact, p57 is expressed in TG cells during G
phase but not during S phase (Hattori et al., 2000; Ullah et al.,
2008).
Up-regulation of cyclin E in late G1 phase activates Cdk2, which
phosphorylates RecQ4 and Treslin (Table 1; Figure 5), thereby
driving the transition from G1 to S phase through assembly of
preICs. Thus, premature expression of APC•Cdh1 activity trig-
gers endoreplication by simultaneously preventing mitosis under
conditions that allow preRC assembly. Once this occurs, the mol-
ecular events that initiate and maintained endocycles in G phase
arrested cells (Figure 8) appear to be the same as those that initiate
and maintain S phase in mitotic cell cycles (Figures 3 and 4). They
are both driven by a series of feedback loops in which phospho-
rylation by CDK activities, ubiquitination by E3 ubiquitin ligases,
and inhibition of CDK activities by specific inhibitors arrest activ-
ities in one phase in order to allow new activities to drive the cell
into the next phase. Opposing oscillations in cyclin E levels and
APC activity allow assembly of preRCs followed by a new round
of genome duplication.
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FIGURE 7 | Activating endocycles in the mouse trophectoderm lineage.
Chk1 is the effector kinase for two checkpoints. The “DNA replication
checkpoint” prevents premature mitosis in response to DNA damage and
stalled replication forks. These events activate (+) the ATR kinase that
activates the Chk1 kinase that inhibits (⊥) the CDC25 phosphatase through
site specific phosphorylation. Since CDC25 is required to activate Cdk1,
inhibition of CDC25 prevents entrance into mitosis. The “G2-restriction point”
prevents expression of p57 and p21 in response to mitogen stimulation. In
the case of trophoblast stem (TS) cells, the mitogen is FGF4. In the presence
of FGF4, TS cells express the p21 and p57 genes, but Chk1 phosphorylates
the p21 and p57 proteins, thereby targeting them for degradation by the 26S
proteasome. This prevents TS cells from exiting their mitotic cell cycle. In the
absence of FGF4, Chk1 protein is degraded, thereby up-regulating p57 and
p21. A feedback loop exists in which p21 could sustain suppression of Chk1
expression in trophoblast giant (TG) cells (Gottifredi et al., 2001). Inhibition of
Cdk1 by p57 triggers endoreplication and differentiation into TG cells. This
event could be facilitated by p21-dependent down-regulation of Emi1, a
specific inhibitor of the APC (Lee et al., 2009). The APC targets mitotic cyclins
and Geminin for degradation, thereby promoting origin licensing. The absence
of Chk1 in TG cells allows p57 protein levels to oscillate. As CcnE levels
increase, Cdk2•CcnE will eventually phosphorylate p57 at a CDK-specific site,
thereby targeting it for degradation.
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FIGURE 8 | Sustaining endocycles in the mouse trophectoderm
lineage. Oscillation of APC activity and the levels of CDK-specific
inhibitors and Geminin (Gmnn) are inversely related to oscillation of cyclin
E (broken gray line). APC activity and CDK inhibitor levels are high in G
phases but low in S phases, whereas cyclin E is low in G phases but high
in S phases. Cdk2•CcnE activity is required to begin S phase. Endocycles
result from a sequence of feedback loops, resulting from phosphorylation
events by Cdk2•CcnE, and ubiquitination events by CRL1 and the APC.
Ubiquitination by CRL1 requires prior CDK-dependent phosphorylation of
its substrate. These events inhibit the activity of their protein targets and
cause them to be degraded by the 26S proteasome (→∅). Protein names
are those for mammals.
PERIODIC OSCILLATIONS IN S PHASE PROTEIN KINASES
As with mitotic cell cycles, periodic oscillations in protein kinase
activities involve the APC (Figure 3). However, genetic and bio-
chemical data from studies on Drosophila demonstrate that only
APC•Fzr (Fzr is the fly homolog of Cdh1) is essential for endocy-
cles (Sigrist and Lehner, 1997; Schaeffer et al., 2004; Garci-Higuera
et al., 2008). The activities of both APC•Fzr and Cdk2•Cyclin E
oscillate during endocycles in flies, and these oscillations appear
to be driven by changes in Cyclin E levels. Of critical impor-
tance is the fact that Cdk2•Cyclin E inactivates Fzr (Sigrist and
Lehner, 1997), suggesting that APC•Fzr oscillations are driven by
periodic inhibition of Fzr by Cdk2•Cyclin E (Narbonne-Reveau
et al., 2008; Zielke et al., 2008). Low Cdk2•Cyclin E activity allows
high APC•Fzr activity, which in turn, degrades mitotic cyclins and
Geminin, thereby allowing assembly of preRCs. High Cdk2•Cyclin
E activity inactivates APC•Fzr, thereby allowing the onset of S
phase in the presence of Geminin (Zielke et al., 2008). In addi-
tion, the CDK-specific inhibitor Dacapo (the fly homolog of p27)
promotes replication licensing during Drosophila endocycles by
reinforcing low CDK activity during G phase, a role that it appears
to play during mitotic cell cycles as well (Hong et al., 2007). The
reiteration of these events,driven by the oscillation of Cdk2•Cyclin
E, likely drives the progression of endocycles (Narbonne-Reveau
et al., 2008; Zielke et al., 2008). Based on mammalian mitotic cell
cycles, changes in Cyclin E levels are likely driven by changes in
Cdk2•Cyclin A activity, although this remains to be shown.
Mammals appear to sustain endocycles in the same manner
as flies, but with some additional detail (Ullah et al., 2009b).
In Drosophila, Cyclin E is required to drive S phase in both
mitotic cell cycles and endocycles, whereas in mammals CcnE is
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required only for endocycles (Geng et al., 2003; Parisi et al., 2003).
In Drosophila, endocycles occur under conditions where mitotic
cyclins A and B are suppressed, whereas the level of CcnB1 in
TG cells remains unchanged from that in TS cells, and the levels
of CcnA2 and CcnE1 decrease markedly after the first endocycle
(Ullah et al., 2008). Of the nine human CDKs, only Cdk1 can
substitute for Cdk2 in driving endocycle S phases (Ullah et al.,
2008). Whether or not the same is true in flies remains to be
determined. As with flies, oscillation of APC•Cdh1 activity is
essential for endocycles in mice (Garci-Higuera et al., 2008; Ma
et al., 2009). Thus, during G phase, APC•Cdh1 and p57 (and pre-
sumably p27, the mammalian ortholog of Dacapo) suppress CDK
activity to allow preRC assembly. Cdk2•CcnE also phosphorylates
Cdc6, thereby protecting Cdc6 from APC-dependent proteolysis
until it is dephosphorylated and assembled into preRCs (Mailand
and Diffley, 2005). The appearance of Cdk2•CcnE activity trig-
gers S phase with concomitant synthesis of Geminin. Geminin
and Cdk2•CcnA activity are both required to suppress DNA re-
replication in mitotic cell cycles (Zhu and Depamphilis, 2009) and
presumably in endocycles as well. Moreover, Cdk2•CcnA phos-
phorylates CcnE, thereby enabling CRL1•Skp2 to target CcnE
for ubiquitin-dependent degradation. In the absence of CcnE,
APC•Cdh1 reappears and mediates ubiquitin-dependent degra-
dation of Geminin. In the absence of Cdk1 activity, oscillation of
APC activity also requires its phosphorylation by Cdk2•CcnA (Ma
et al., 2009).
THE ROLE OF p57
Endocycles in TG cells require that p57 levels oscillate to allow
preRC assembly in the absence of CDK activity (G phase) followed
by their conversion into preICs in the presence of CDK activity
(S phase). Thus, suppression of Chk1 activity in TG cells allows
expression of p57 during G phase (Ullah et al., 2011), whereas the
presence of Cdk2•CcnE activity in TG cells allows p57 to be tar-
geted for degradation during S phase (Hattori et al., 2000; Kamura
et al., 2003). Selective degradation of CcnE allows the level of p57
to again rise due to the absence of Chk1 and the loss of Cdk2•CcnE
activity, and the cell returns to G phase (Figure 8).
THE ROLE OF GEMININ
Genetic ablation of Geminin in mouse embryos causes excess
DNA replication in eight-cell embryos and expression of tro-
phoblast specific genes, suggesting that suppression of Geminin
triggers endoreplication and differentiation of pluripotent blas-
tomeres into trophectoderm (Gonzalez et al., 2006). Moreover,
silencing Geminin in mouse embryonal carcinoma and ES cells
can result in loss of stem cell identity and differentiation into tro-
phoblast cells (Yang et al., 2011). However, others have reported
that genetic ablation of Geminin induces DNA re-replication and
apoptosis in eight-cell embryos (Hara et al., 2006), and that sup-
pression of Geminin expression does not affect the ability of ES
cells to maintain or exit pluripotency (Yellajoshyula et al., 2011).
Moreover, expression of Geminin is not suppressed during differ-
entiation of TS cells into TG cells (Ullah et al., 2008), and Geminin
levels in Drosophila continue to oscillate during endocycles as they
do during mitotic cell cycles (Zielke et al., 2008). The simplest
explanation is that Geminin prevents DNA re-replication during
both mitotic cell cycles and endocycles. Changes in gene expres-
sion that occur during Geminin depletion appear to be an indirect
consequence of the loss of DNA replication control (Kerns et al.,
2012).
SUMMARY
Errors in genome duplication result in the accumulation of muta-
tions that eventually lead to cancer, a disease in which cells
continue to proliferate under conditions where normal cells are
either quiescent or terminally differentiated (DePamphilis and
Bell, 2011). Therefore, the nuclear DNA component is dupli-
cated once but only once each time a cell divides. To this end,
genome duplication is tightly regulated by multiple convergent
pathways and inextricably linked to mitosis; DNA re-replication
results in apoptosis. Remarkably, only eight (Cdk1, Cdk2, Cdk4,
Cdk6, Cdk7, Cdc7, Chk1, Chk2) protein kinases orchestrate these
events directly, and only four of them (Cdk1, Cdk7, Cdc7, Chk1)
are essential for mammalian development. This paucity in control
of such critical events in our biology occurs through replaceable
parts and functional redundancy. The extreme example is Cdk4
and Cdk6; they are functionally redundant in the G0 to G1 transi-
tion regardless of which of three cyclin D proteins binds to them.
In contrast, the Cdk1 and Cdk2 play different roles in the mitotic
cell cycle depending on whether they associate with cyclin A, B,
or E. Cdk1 can replace Cdk2 in S phase, but Cdk2 cannot replace
Cdk1 in mitosis. Similarly, Chk1 can replace Chk2, but Chk2 can-
not replace Chk1 in either its DNA damage checkpoint role or
its role in TS cell differentiation. Given the importance of pre-
venting excess DNA replication during cell division, the fact that
some mammalian cells are developmentally programmed to exit
their mitotic cell cycle and differentiate into viable polyploid cells
is remarkable. Among the eukarya, the most commonly employed
mechanism for this event is endoreplication, whereby selective
inhibition of Cdk1 activity occurs under conditions that permit
re-licensing of replication origins without passing through mitosis
or cytokinesis and without undergoing apoptosis. Chk1 activity is
also suppressed, at least in the example of TG cells, apparently as
part of the anti-apoptosis mechanism. The remaining members
of the protein kinase “octet” remain in their normal mitotic cell
cycle roles. We suggest that focusing on the proteins that interact
with“the octet” will provide critical insight to the regulation of cell
division, its relationship with human disease, and novel directions
in cancer therapy.
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